• CLS Holdings USA (CLSH) has announced record financial results for January 2020
  • The month saw C$1.15 million in unaudited revenue – an increase of 49 per cent over January 2019
  • Consolidated gross margins have also increased to 59 per cent over the last 12 months
  • Shares in CLS Holdings are currently down 2.38 per cent to 20.5 cents, with a market cap of C$30.27 million

Diversified cannabis company, CLS Holdings USA (CLSH), has reported record financial results for January.

The first month of 2020 has seen C$1.15 million in unaudited consolidated revenue – an increase of 49 per cent from January 2019’s posting of C$0.73 million.

Consolidated gross margins are also up 33 per cent over the 12-month period to 59 per cent.

“The month of January represented the best overall month to date for our operating divisions. We continued our positive momentum from CY19 into CY20,” said CLS Holdings President and COO, Andrew Glashow.

“While January of 2019 saw a drop-off in revenue after the holiday period, we saw a continued acceleration in revenue and customer growth this January.”

CLS Holdings also reported a 136 per cent increase in the total number of dispensary customers, from 10,908 in January 2019 to 25,776 in January 2020.

The company says that this increase is due in part to the installation of a new point of sale system, which has streamlined checkout times and allowed for more engaged interactions with customers.

In addition to promising financial results, CLS Holdings has engaged in several third-party wholesale manufacturing agreements at its North Las Vegas facility. 

“Moving forward in 2020, we expect to see substantial revenue and margin expansion from our newly built conversion and extraction facility in North Las Vegas, Nevada,” added Mr. Glashow. 

“We have begun to manufacture for a number of third parties and are creating an entire new line of effect-based products to be launched soon. These products will be unique and differentiated in the Nevada cannabis market.” 

Shares in CLS Holdings are currently down 2.38 per cent to 20.5 cents, with a market cap of C$30.27 million.

More From The Market Online

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.

The Market Online’s Weekly Cannabis Report – April 12, 2024

Canada’s cannabis stock market fluctuated this week thanks to a combination of industry-specific developments and broader market trends